SCHEMBL17614043

SCHEMBL17614043

CCCCOc1ccc(Cl)c(I)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 2/20 0.50
▸ GPR84 Q9NQS5 1/20 0.50
▸ L3MBTL1 Q9Y468 2/20 0.46
▸ THRA P10827 2/20 0.45
▸ THRB P10828 2/20 0.45
▸ KMT2A Q03164 2/20 0.44
▸ NPC1 O15118 2/20 0.44
▸ RAB9A P51151 2/20 0.44
▸ SMN1; SMN2 Q16637 1/20 0.44
▸ HSD17B10 Q99714 1/20 0.44
▸ LTA4H P09960 3/20 0.43
▸ NR5A1 Q13285 1/20 0.42
▸ CA12 O43570 1/20 0.41
▸ CA1 P00915 1/20 0.41
▸ CA2 P00918 1/20 0.41
▸ CA3 P07451 1/20 0.41
▸ CA4 P22748 1/20 0.41
▸ CA6 P23280 1/20 0.41
▸ CA7 P43166 1/20 0.41
▸ CA9 Q16790 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27987992 0.85 KDM4E (0.50) KDM4EL3MBTL1THRATHRBKMT2A
SCHEMBL544330 0.85 NQO1 (0.50) KDM4EGPR84L3MBTL1KMT2ANPC1
SCHEMBL12885024 0.82 KDM4E (0.69) KDM4EGPR84L3MBTL1THRATHRB
SCHEMBL14473813 0.79 GAA (0.59) KDM4EGPR84L3MBTL1KMT2ANPC1
SCHEMBL3790208 0.79 KDM4E (0.51) KDM4EGPR84L3MBTL1THRATHRB
SCHEMBL24262858 0.78 GPR84 (0.50) KDM4EGPR84L3MBTL1THRATHRB
SCHEMBL256301 0.78 KDM4E (0.46) KDM4EL3MBTL1THRATHRBKMT2A
SCHEMBL15625385 0.78 L3MBTL1 (0.71) KDM4EGPR84L3MBTL1THRATHRB
SCHEMBL20503253 0.78 KDM4E (0.63) KDM4EL3MBTL1THRATHRBKMT2A
SCHEMBL3785877 0.78 DRD4 (0.54) KDM4EL3MBTL1THRATHRBKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2723744-B1 1-ARYL-4-METHYL-[1,2,4]TRIAZOLO[4,3-a]QUINOXALINE DERIVATIVES JANSSEN PHARMACEUTICA NV (BE) 2016-03-23 — — EP disclosed
Send feedback